NASDAQ:BTMD biote (BTMD) Stock Price, News & Analysis $3.36 -0.10 (-2.89%) Closing price 04:00 PM EasternExtended Trading$3.53 +0.17 (+5.06%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About biote Stock (NASDAQ:BTMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get biote alerts:Sign Up Key Stats Today's Range$3.22▼$3.4150-Day Range$3.07▼$5.8052-Week Range$3.04▼$8.44Volume137,170 shsAverage Volume183,293 shsMarket Capitalization$183.83 millionP/E Ratio12.92Dividend YieldN/APrice Target$8.00Consensus RatingBuy Company Overviewbiote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.Read More… Remove Ads biote Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreBTMD MarketRank™: biote scored higher than 69% of companies evaluated by MarketBeat, and ranked 280th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus Ratingbiote has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst Coveragebiote has only been the subject of 1 research reports in the past 90 days.Read more about biote's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-28.00% Earnings GrowthEarnings for biote are expected to decrease by -28.00% in the coming year, from $0.75 to $0.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of biote is 12.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.92.Price to Earnings Ratio vs. SectorThe P/E ratio of biote is 12.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.25.Read more about biote's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.38% of the float of biote has been sold short.Short Interest Ratio / Days to Coverbiote has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in biote has recently increased by 10.39%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend Yieldbiote does not currently pay a dividend.Dividend Growthbiote does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.38% of the float of biote has been sold short.Short Interest Ratio / Days to Coverbiote has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in biote has recently increased by 10.39%, indicating that investor sentiment is decreasing significantly. News and Social Media4.1 / 5News Sentiment1.45 News Sentimentbiote has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for biote this week, compared to 1 article on an average week.Search Interest4 people have searched for BTMD on MarketBeat in the last 30 days. MarketBeat Follows2 people have added biote to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, biote insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,915,138.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.90% of the stock of biote is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.68% of the stock of biote is held by institutions.Read more about biote's insider trading history. Receive BTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter. Email Address BTMD Stock News Headlinesbiote Corp. (NASDAQ:BTMD) Major Shareholder Acquires $351,920.00 in StockApril 3 at 5:37 AM | insidertrades.comInsider Buying: biote Corp. (NASDAQ:BTMD) Director Buys 38,104 Shares of StockMarch 19, 2025 | insidertrades.comYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.April 3, 2025 | Premier Gold Co (Ad)biote Corp. (NASDAQ:BTMD) Major Shareholder Purchases $2,415,000.00 in StockMarch 18, 2025 | insidertrades.combiote Corp. (BTMD): Insider Were Buying In Q1 2025April 2 at 3:50 PM | msn.comMarc Beer Buys Handful Of Shares In bioteMarch 20, 2025 | finance.yahoo.combiote (BTMD) Gets a Buy from Craig-HallumMarch 19, 2025 | markets.businessinsider.comBiote price target lowered to $6 from $8 at TD CowenMarch 18, 2025 | markets.businessinsider.comSee More Headlines BTMD Stock Analysis - Frequently Asked Questions How have BTMD shares performed this year? biote's stock was trading at $6.18 at the beginning of 2025. Since then, BTMD shares have decreased by 45.6% and is now trading at $3.36. View the best growth stocks for 2025 here. How were biote's earnings last quarter? biote Corp. (NASDAQ:BTMD) posted its quarterly earnings data on Thursday, August, 10th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.34. The business had revenue of $49.26 million for the quarter, compared to analyst estimates of $46.76 million. biote had a net margin of 5.20% and a negative trailing twelve-month return on equity of 32.41%. How do I buy shares of biote? Shares of BTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of biote own? Based on aggregate information from My MarketBeat watchlists, some other companies that biote investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Netflix (NFLX). Company Calendar Last Earnings8/10/2023Today4/03/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BTMD CIK1819253 Webbiote.com Phone844-604-1246Fax212-616-9601Employees194Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+139.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.18 Trailing P/E Ratio12.85 Forward P/E Ratio4.45 P/E GrowthN/ANet Income$3.32 million Net Margins5.20% Pretax Margin5.99% Return on Equity-32.41% Return on Assets22.26% Debt Debt-to-Equity RatioN/A Current Ratio1.50 Quick Ratio1.16 Sales & Book Value Annual Sales$197.19 million Price / Sales0.93 Cash Flow$0.35 per share Price / Cash Flow9.60 Book Value($0.58) per share Price / Book-5.76Miscellaneous Outstanding Shares54,710,000Free Float46,784,000Market Cap$182.73 million OptionableNot Optionable Beta1.07 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:BTMD) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.